CDER: Avastin Breast Cancer Claim Undermines Approval ProcessMay 17, 2011OncologyWomen's HealthBreast Cancer
Genentech Appeals to FDAs Regulatory Flexibility on AvastinMay 16, 2011OncologyWomen's HealthBreast Cancer